A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.
Hormone replacement therapy during menopause appears to be linked to a toxic brain protein that’s a hallmark of Alzhe ...
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...
A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's ...
"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...
A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...
Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...
Alzheimer’s disease affects more women than men. Recognizing the early symptoms—such as memory loss and mood swings —can lead ...
Lantheus Holdings, Inc.'s stock soars 55%, fueled by Pylarify and strategic acquisitions in Alzheimer's and oncology. Click ...
US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...